March 11, 2024 · Form 4 insider transaction
Levitz Michael L sold 1,725 shares of Anika Therapeutics, Inc. at $25.42 per share, a transaction worth $43.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.; Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.